Orthofix Medical Inc. and LimaCorporate have announced a licensing partnership for the U.S. market to provide a novel solution for patients with chronic high hip dislocation, according to a press release.
The partnership combines Orthofix’s Fitbone intramedullary nail system with LimaCorporate’s 3D-printed pelvic fixation solution to allow for correction in patients with leg-length discrepancy prior to total hip arthroplasty, according to the release.
“We are excited to partner with LimaCorporate to bring together our complementary technologies to satisfy the previously unmet needs of patients requiring a personalized and unique complex hip replacement solution,” Kimberley Elting, president of global orthopedics at Orthofix, said in the release. “This solution will be the only offering in the U.S. for certain patients with hip dysplasia or abnormalities of the hip leading to leg-length discrepancy, and reflects the strength and versatility of the Fitbone platform,” Elting added.
“This partnership is an important opportunity for us to explore new segments and support even more U.S. surgeons and their patients,” Emmanuel Bonhomme, CEO of LimaCorporate, said in the release. “Additionally, the collaboration with the ProMade Point of Care Center (PoC Center), which opened last year, will bring added value in terms of experience and knowledge combined with our market-leading technologies in custom prosthesis.”